When comparing the GIS distributions of BRCA1/2-deficient samples, TNBC tumors were significantly different from ER + BC tumors (p < 0.001; Fig. 1b), but not significantly different from ovarian cancer tumors (p = 0.35; Fig. 1b). The gene discussed is BRCA1; the disease is ovarian carcinoma.